|
US2020360461A1
|
|
Orodispersible film composition comprising enalapril for the treatment of hypertension in a pediatric population
|
|
ZA201905253B
|
|
Pharmaceutical composition comprising naltrexone microspheres and method of preparation thereof
|
|
ZA201905132B
|
|
Pharmaceutical composition comprising a somatostatin peptide analogue
|
|
ZA201904747B
|
|
Long acting injectable pharmaceutical composition comprising paliperidone palmitate and method of preparation thereof
|
|
ZA201904685B
|
|
Pharmaceutical composition comprising an atypical antipsychotic drug and method for the preparation thereof
|
|
WO2021008668A1
|
|
Preservative free pharmaceutical composition for ophthalmic administration containing cyclosporine
|
|
EP3810623A1
|
|
A novel process for the preparation of sglt-2 inhibitors
|
|
CN112262121A
|
|
Novel process for the preparation of tapentadol
|
|
ZA201902046B
|
|
Prolonged release formulation comprising tacrolimus
|
|
ZA201902044B
|
|
Sustained release composition comprising tapentadol and method of preparation thereof
|
|
ZA201902045B
|
|
Sustained release composition comprising tapentadol oxalate and method of preparation thereof
|
|
ZA201806527B
|
|
Pharmaceutical composition comprising vildagliptin and metformin and method of preparation thereof
|
|
ZA201806258B
|
|
Pharmaceutical composition comprising a magnesium oxide salt complex of febuxostat and method for the preparation thereof
|
|
ZA201806095B
|
|
Pharmaceutical composition comprising an immunomodulatory agent and method for the preparation thereof
|
|
ZA201804996B
|
|
Ophthalmic pharmaceutical composition containing brinzolamide and timolol and method for the preparation thereof
|
|
ZA201804579B
|
|
Pharmaceutical composition comprising an iron chelating agent and method for the preparation thereof
|
|
ZA201802863B
|
|
Soft gel capsule comprising a selective estrogen receptor modulator
|
|
KR20190095513A
|
|
Method for producing high molecular weight biodegradable polymer
|
|
ZA201707651B
|
|
Ophthalmic pharmaceutical composition containing a combination of brinzolamide and brimonidine and method of preparation thereof
|
|
EP3472134A1
|
|
Process for preparing compounds useful as intermediates for the preparation of raltegravir
|
